(2S,4R)-4-(9H-Pyrido[3,4-b]indol-1-yl)-1,2,4-butanetriol

Metabolite details

Identifier

YPOORAFYDFLOBZ-UHFFFAOYSA-N

InChI Key

YPOORAFYDFLOBZ-UHFFFAOYSA-N

IUPAC name

4-(9H-pyrido[3,4-b]indol-1-yl)butane-1,2,4-triol

Preferred name

(2S,4R)-4-(9H-Pyrido[3,4-b]indol-1-yl)-1,2,4-butanetriol

INN name

—

Synonym

—

ChEBI

CHEBI:173933

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Metabolism Disorder Promotes Isoproterenol-induced Myocardial Injury in Mice with High Temperature and High Humidity and High-Fat Diet
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_vs_nsPEF_7_day
• 2:00 AM_Membrane_vs_2:00 AM_Net
• Control_vs_Isoproterenol
• Control_vs_CSD
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d
• Control_vs_BP3_Low_Concentration